Biothera will present research at the American Society of Clinical Oncology (ASCO) annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG® immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
Help employers find you! Check out all the jobs and post your resume.
